河北医科大学学报 ›› 2025, Vol. 46 ›› Issue (5): 561-566.doi: 10.3969/j.issn.1007-3205.2025.05.011

• • 上一篇    下一篇

Nrf2-Keap1-ARE信号通路在妊娠期糖尿病子代胰岛素抵抗发生中的作用的机制研究

  

  1. 新疆维吾尔自治区人民医院产科,新疆 乌鲁木齐 830001

  • 出版日期:2025-05-25 发布日期:2025-05-23
  • 作者简介:努尔比也·地里夏提(1985-),女,维吾尔族,新疆乌鲁木齐人,新疆维吾尔自治区人民医院主治医师,医学学士,从事产科疾病诊治研究。

  • 基金资助:
    新疆少数民族科技人才特殊培养计划科研项目(2022D03016)

The role of Nrf2-Keap1-ARE signaling pathway in the development of insulin resistance in the offspring of patients with gestational diabetes

  1. Department of Obstetrics, People′s Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China

  • Online:2025-05-25 Published:2025-05-23

摘要: 目的 研究Nrf2-Keap1-ARE信号通路在妊娠期糖尿病(gestational diabetes mellitus,GDM)子代中的作用机制,特别关注其在胰岛素抵抗发生中的调控作用。
方法 将60只造模成功的大鼠随机分为空载慢病毒组(20只)、Nrf2-siRNA组(20只)、胰岛素干预组(20只),3组大鼠妊娠第5天进行干预,空载慢病毒组造模完成后尾静脉注射空白病毒载体200 μL,Nrf2-siRNA组注射含有Nrf2 siRNA 载200 μL,胰岛素干预组每日在大鼠右下腹部注射甘精胰岛素4 U/kg进行注射,3组均干预2周,对子代大鼠出生第8周、16周和24周时时糖耐量及胰岛素抵抗、胰岛素耐量、胰岛组织中氧化应激指标的检测、胰岛组织Nrf2、Keap1和ARE蛋白含量和mRNA水平分析。
结果 空载慢病毒组在出生第8周、16周和24周时的胰岛素抵抗指数分别为0.65±0.13、1.03±0.31和2.81±0.65;Nrf2-siRNA组分别为0.97±0.22、1.74±0.77和2.98±0.95;胰岛素干预组分别为1.08±0.39、2.66±0.92和4.42±1.04。空载慢病毒组在出生第8周、16周和24周时的血糖浓度分别为(2.18±0.09)、(3.05±0.35)和(4.34±2.10)mmol/L;Nrf2-siRNA组分别为(2.58±0.37)、(3.18±0.77)和(4.92±2.08)mmol/L;胰岛素干预组分别为(2.89±0.39)、(4.69±1.47)和(6.18±2.33)mmol/L。在子代大鼠胰岛组织中,空载慢病毒组显示更高的氧化应激水平,而胰岛素干预组则表现出较低的氧化应激(P<0.05);空载慢病毒组的Nrf2、Keapl、AREmRNA含量均低于Nrf2-siRNA组和胰岛素干预组(P<0.05)。
结论 Nrf2-Keap1-ARE信号通路可能通过调节氧化应激水平影响胰岛素敏感性,从而影响妊娠期糖尿病子代的糖代谢状态。激活该信号通路有望成为治疗GDM及其相关并发症的潜在治疗策略,为个性化的临床治疗提供新思路。


关键词: 糖尿病, 妊娠, 胰岛素抵抗, Nrf2-Keap1-ARE信号通路

Abstract: Objective To conduct an in-depth study of the mechanism of Nrf2-Keap1-ARE signaling pathway in the offspring of patients with gestational diabetes mellitus (GDM), and to pay special attention to its regulatory role in the occurrence of insulin resistance. 
Methods Sixty successfully modeled rats were randomly divided into an empty lentivirus group (20 rats), an Nrf2 siRNA group (20 rats), and an insulin intervention group (20 rats). Rats in the three groups were intervened on the 5th day of pregnancy. After the empty lentivirus group completed modeling, 200uL of blank virus vector was injected into the tail vein. The Nrf2 siRNA group was injected with 200uL of Nrf2 siRNA vector. The insulin intervention group was injected with 4 U/kg of glargine insulin daily in the lower right abdomen of the rats. Three groups were all intervened for 2 weeks, and the glucose tolerance and insulin resistance, insulin tolerance, oxidative stress indicators in pancreatic tissue, Nrf2, Keap1, and ARE protein content and mRNA levels in pancreatic tissue of offspring rats were analyzed at 8, 16, and 24 weeks after birth. 
Results The insulin resistance indexes at 8, 16, and 24 weeks after birth were 0.65±0.13, 1.03±0.31, and 2.81±0.65, respectivelyin the empty lentivirus group, 0.97±0.22, 1.74±0.77, and 2.98±0.95, respectivelyin the Nrf2 siRNA groups, and 1.08±0.39, 2.66±0.92, and 4.42±1.04, respectively in the insulin intervention group. The blood glucose concentrations at 8, 16, and 24 weeks after birth were (2.18±0.09), (3.05±0.35), and (4.34±2.10) mmol/L, respectively in the empty lentivirus group, (2.58±0.37), (3.18±0.77), and (4.92±2.08) mmol/L, respectively in the Nrf2 siRNA group, and (2.89±0.39), (4.69±1.47), and (6.18±2.33) mmol/L, respectively in the insulin intervention group. In the pancreatic tissue of offspring rats, the empty lentivirus group showed higher levels of oxidative stress, while the insulin intervention group showed lower levels of oxidative stress (P<0.05). The mRNA levels of Nrf2, Keapl, and ARE in the empty lentivirus group were lower than those in the Nrf2 siRNA group and insulin intervention group (P<0.05). 
Conclusion Nrf2-Keap1-ARE signaling pathway may affect insulin sensitivity by regulating the level of oxidative stress, thus affecting the glucose metabolism of diabetic offspring during pregnancy. Activating this signaling pathway is expected to become a potential therapeutic strategy for the treatment of GDM and its related complications, providing new ideas for personalized clinical treatment. 


Key words: diabetes, gestational, insulin resistance, Nrf2 Keap1 ARE signaling pathway